Intraventricular Tigecycline
Abstract This case report discusses a novel therapeutic strategy in managing a severe intracranial infection caused by multidrug-resistant Stenotrophomonas maltophilia utilizing intraventricular tigecycline. The favorable clinical outcome observed suggests a potential promising role of intraventricular tigecycline in treating drug-resistant S. maltophilia meningitis, underscoring the necessity for further investigation and validation.
Authors
- Austin Chan (ORCID: https://orcid.org/0000-0002-6839-1832)
- Elizabeth C. Nnakwue
- Manish I. Patel (ORCID: https://orcid.org/0000-0003-1409-9171)
- Jacques Christian Charlier
- Toni M. Jackson
Institutions
- Grady Health System (US)
- Morehouse School of Medicine (US)
Publication Details
- Journal
- Infectious Diseases in Clinical Practice
- Published
- 2024-08-13
- DOI
- https://doi.org/10.1097/ipc.0000000000001389
- Citations
- 1
- Primary Topic
- Infections and bacterial resistance
- Type
- article
- Field-Weighted Citation Impact
- 0.62